youtor.org
New drug OTX15 shows early promise in fighting acute myeloid leukaemia
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=eux6hybn5I8
Visit http://www.ecancer.org for more. • Dr Cvitkovic (Oncoethix, Lausanne, Switzerland) talks to ecancertv at the AACR conference about the Phase I clinical trial of OTX015, in patients with haematologic malignancies including acute myeloid leukaemia. • OTX15 works by inhibiting BET bromodomain proteins 2/3/4, which play a significant part in the growth of cancer cells. • Cvitkovic hopes to expand the study to look at its use in solid tumours in the near future.
#############################
